Infectious disease is uniquely demanding among medical specialties: the pathogens evolve, resistance patterns shift, outbreak threats emerge without warning, and treatment guidelines can become obsolete within a year of publication. This guide covers practical approaches to staying genuinely current across antimicrobial stewardship, emerging infections, and rapidly evolving resistance data.
In most specialties, practice change is incremental. A cardiologist who misses one year of literature is practicing on slightly dated evidence. An infectious disease physician who misses one year may be recommending antibiotics with 40% resistance rates in their local hospital, or missing a first-line treatment change for a common pathogen. The stakes of currency are higher because the underlying biology is less stable.
The COVID-19 pandemic accelerated this problem. The volume of infectious disease literature published between 2020 and 2023 dwarfed the preceding decade in many areas. ID physicians who maintained reading habits through that period are meaningfully better positioned than those who abandoned structured reading under clinical pressure.
The essential reading list for an ID physician in 2026 includes:
No area of ID literature changes faster than resistance epidemiology. What was first-line for CRE bacteremia in 2020 is now second-line in many centers. The publications that best track this are:
A critical point often missed: The national resistance data and your local antibiogram may differ substantially. A carbapenem susceptibility rate of 85% nationally may mask a 50% rate at your hospital for specific gram-negatives. Reading the national literature without comparing it to your institutional data leads to suboptimal prescribing decisions.
ID physicians are the specialty most likely to be asked to respond to novel outbreaks, unusual presentations, or travel-related infections. Staying current on emerging threats requires monitoring beyond traditional journals:
IDSA publishes and updates treatment guidelines for dozens of infectious conditions. These represent the most clinically actionable literature an ID physician can read, and they are periodically updated to reflect new evidence. Guidelines with high update frequency include:
A systematic approach is to review the IDSA guidelines page quarterly and note any updated or newly published guidelines in your subspecialty areas.
IDWeek (annual, October, IDSA/SHEA/HIVMA/SIDP) is the primary conference for clinical ID. ASM Microbe covers microbiology and emerging science. Both publish abstract collections that are searchable before presentations. A highly efficient strategy is to read only the late-breaking abstract session from IDWeek each year — typically 8 to 12 presentations on the highest-impact clinical data — rather than attempting comprehensive coverage of the full meeting.
Stewardship has become a core function of hospital ID programs. The dedicated literature includes ICHE, Open Forum Infectious Diseases (OFID), and the IDSA-SHEA stewardship guidelines. Key topics evolving rapidly in this area include IV-to-oral conversion programs, procalcitonin-guided therapy duration, and de-escalation protocols for gram-negative bacteremia.
MDInformed curates the five most clinically relevant papers from 35 million publications and delivers them as a structured digest — free forever.
Join the waitlist →